March 9, 2018

March 09, 2018

VIDEO: Changes in standard of care for sentinel node positive melanoma

Healio – March 8

In this video commentary from HemOnc Today New York, Vernon K. Sondak, MD, discussed changes in the standard of care for patients with sentinel node-positive melanoma.

Advanced Urology Institute Announces Use of SpaceOAR Hydrogel

Health Technology – March 9

Dr. Finkelstein has published journal articles and book chapters resulting in 5000+ reference citations. Recognizing the impact he could have as a radiation oncologist, Dr. Finkelstein joined Moffitt Cancer Center completing chief residency and 21st Century Oncology as National Director of Translational Research.

Collaboration key to identification, incorporation of biomarkers for immuno-oncology

Healio – March 8

“As translational researchers or researchers in the laboratory, we need to think about, can we bring what we are measuring into the clinic? Is it easy enough?” Nikhil I. Khushalani, MD, associate member and vice chair of cutaneous oncology at Moffitt Cancer Center and associate professor at USF Morsani College of Medicine, said during his presentation. 

Moffitt Cancer Center named one of the Top 10 Nonprofit Companies for Executive Women

Tampa Dispatch – March 6

“We are thrilled that NAFE recognized Moffitt’s commitment to the advancement of women into leadership and top executive positions,” said Mariana Bugallo-Muros, Moffitt’s vice president and chief human resources officer.

Symptom Control in Functional NETs

OncLive – March 6

Jonathan R. Strosberg, MD: Neuroendocrine tumors are often characterized by the propensity to produce hormones. The most common one is carcinoid syndrome, which is predominantly caused by serotonin secretion but also by other vasoactive substances. 

Acute Lymphoblastic Leukemia: Challenges in MRD Testing

OncLive – March 6

Bijal D. Shah, MD: Exactly. That’s my point. We know that pushing beyond 10-4 in Philadelphia-positive ALL is relevant. I suspect—not just suspect, the UKALL data that were recently published also demonstrated it—that using a really specific PCR pushing below that 10-4threshold was also prognostic.

Guardian angel on the other side of the world

WINK – March 5

The doctors at Moffitt Medical Center in Tampa admitted her almost immediately for grueling weeks of chemotherapy. As she fought her way into remission, doctors recommended she get a stem cell transplant… Doctors found a perfect match for Andrea in Germany. Donors take Filgratism to build up stem cells in the blood. Doctors then collect the cells from the blood and sent them from Europe to Florida overnight. Just hours later, Andrea was on her way to a brand new life.

Angela and James Miller on Their Battle Against Colorectal Cancer

Tallahassee Magazine – March/April 2018

Angela, with Coton Colors, and James, with the Florida Retail Federation, say their employers, coworkers, friends and sons are all helping in James’ fight against colorectal cancer. The boys surprised Dad with a Christmas Eve visit at Moffitt Cancer Center in Tampa.

HPV is causing an oral cancer epidemic in men by outwitting natural defenses

The Philadelphia Inquirer – March 6

Anna R. Giuliano, the researcher at the Moffitt Cancer Center in Tampa, Fla., who led the HIM study, said recurring infections may be due to reactivation of dormant virus, or to auto-inoculation – the man spreads infection from one part of his body to another. Or to something else entirely. Also posted to The Register-Guard, Apalachicola Times and Ledger Enquirer.

Using acupuncture to treat cancer – March 5

She started with weekly treatments and continues it now once every three weeks. Acupuncturist, Dr. Liem Quang le Daom of the Lee Moffitt Cancer Center, says it stimulates the body's natural ability to heal itself. 

Morroni’s annual dinner awards first responders

Tampa Bay Newspapers – March 5

Due to their heroics, 560 people were in attendance, and 50 sponsors. The event raised more than $80,000 for Moffitt Cancer Center Foundation, a 501(c)(3).

Here’s the story behind Hearst’s $75 million investment at Moffitt’s M2Gen

Tampa Bay Business Journal – March 5

M2Gen, a Moffitt Cancer Center subsidiary that uses big data to find ways to treat cancer, drew interest from 32 potential investors before M2Gen agreed to a $75 million investment from Hearst.

Risk Stratification and Management of NETs

OncLive – March 2

Jonathan R. Strosberg, MD: Neuroendocrine tumors are extremely diverse. It’s not really 1 cancer. It’s a family of cancers and is about as heterogenous as we see for a group of cancers. They range from the very slowest growing tumors to the fastest growing. The small cell histology is technically a form of neuroendocrine carcinoma.

Surgical Considerations for Neuroendocrine Tumors

OncLive – March 2

Jonathan R. Strosberg, MD: The role of surgery in locally advanced disease really depends on which organ we’re talking about and what we mean by locally advanced. If we’re talking about pancreatic neuroendocrine tumors, there are some cases where you have invasion of SMA (superior mesenteric artery), SMV (superior mesenteric vein), or portal vein, where the tumor is initially unresectable but can potentially be shrunk with neoadjuvant treatment—either chemotherapy, by itself, a combination of chemotherapy radiation, or maybe even peptide receptor radiotherapy.

MRD Testing in ALL: Sensitivity and Availability

OncLive – March 2

Bijal D. Shah, MD: Anecdotally, we do know the context of Philadelphia-positive leukemias. We’ve seen it. If someone fails to develop a complete molecular remission, we know that patient is at high risk of relapse.



Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.